Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial have?
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial has 199 citations in the OpenAlex counts ScholarIQ stores.
When was Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial published?
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial has 2004 year in the ScholarIQ index.
What is the open-access status of Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial?
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial has closed oa status in the ScholarIQ index.
What is the DOI of Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial?
The DOI for Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial is on the source record.
What is the PMID of Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial?
The PMID for Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial is on the source record.
What is the OpenAlex record for Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial?
The OpenAlex for Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial is on the source record.